- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Current Recommendations Exercise Group
Total 818 results
-
Assiut UniversityCompletedPostoperative PainEgypt
-
Sohag UniversityNot yet recruiting
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV InfectionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Axsome Therapeutics, Inc.CompletedDepression | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
University of OxfordCompletedImmune Response | BCG Infection | Reaction - VaccineUnited Kingdom
-
Avanir PharmaceuticalsTerminatedPseudobulbar Affect (Involuntary Laughing and/or Crying)United States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingBreast CancerUnited States
-
University of FloridaALS Association; Holy Cross Hospital, FloridaCompletedAmyotrophic Lateral SclerosisUnited States
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
Rabin Medical CenterTel Aviv University; The Leona M. and Harry B. Helmsley Charitable TrustRecruiting
-
Eli Lilly and CompanyCompleted
-
Avanir PharmaceuticalsSyneos HealthCompletedPseudobulbar Affect (PBA)United States, Argentina, Brazil
-
Michael Schneider, DC, PhDPatient-Centered Outcomes Research InstituteCompletedLumbar Spinal StenosisUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingRefractory Melanoma | HLA-A2 Positive Cells PresentUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
UNICANCERAstraZeneca; Fondation ARCActive, not recruiting